RxDoctor Payments Data

Mark Agius

Neurology · Woodland, CANPI 1003897349

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $201,113 of the $254,398 with a category attached, or 79.1%. 6 manufacturers reported payments, led by Sanofi at 43.2% of the total. Among neurology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$254,398in general payments, 2019–2025

Across 279 payments — averaging $911.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$110K
  • EMD Serono, Inc.$81K
  • Novartis$34K
  • Genentech USA, Inc.$17K
  • AstraZeneca$12K
  • Biogen$102

What the payments were for

  • Consulting fees$8,2433%
  • Speaking & faculty fees$201,11379%
  • Travel & lodging$38,52715%
  • Food & beverage$6,5153%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi95$109,923
EMD Serono, Inc.113$80,706
Novartis39$33,933
Genentech USA, Inc.14$17,496
AstraZeneca17$12,237
Biogen1$102

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$254,398 in reported general payments places this provider in the 95th percentile of 1,996 neurology providers in California.

See all neurology providers in California →

Other neurology in Woodland

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →